Market Place
Sourcing Support
Newleos unveils with $93M and 4 ex-Roche programs
14 Feb 2025 //
FIERCE BIOTECH
FDA approves Roche’s Evrysdi tablet as first & only tablet for SMA
12 Feb 2025 //
GLOBENEWSWIRE
Novo’s Bispecific for Hemophilia Aces Phase III Pediatric Trial
08 Feb 2025 //
BIOSPACE
Roche’s Gazyva Shows Superiority in Lupus Nephritis in NEJM
07 Feb 2025 //
GLOBENEWSWIRE
FDA Approves Roche’s Susvimo in Diabetes-related Blindness
04 Feb 2025 //
GLOBENEWSWIRE
Roche Gets FDA Approval For HER2-Ultralow Breast Cancer Test
31 Jan 2025 //
GLOBENEWSWIRE
Roche`s Vabysmo crosses $4B mark as Polivy joins blockbuster club
31 Jan 2025 //
FIERCE PHARMA
Roche Pharma India to appoint Rajwinder as general manager
30 Jan 2025 //
ECONOMICTIMES
Roche Reports 7% Sales Growth In 2024, Q4 Sees 9% Growth Streak
30 Jan 2025 //
GLOBENEWSWIRE
Change to the Roche Enlarged Corporate Executive Committee
29 Jan 2025 //
GLOBENEWSWIRE
Roche Gets FDA 510(k) Nod For First Lp(a) Blood Test
29 Jan 2025 //
PR NEWSWIRE
Roche Itovebi Shows Survival Benefit In HR-Positive Breast Cancer
28 Jan 2025 //
GLOBENEWSWIRE
Roche`s Itovebi pads its case with overall survival win
28 Jan 2025 //
REUTERS
Roche Gets FDA Clearance, CLIA Waiver For cobas® liat STI Tests
22 Jan 2025 //
GLOBENEWSWIRE
Roche Gets FDA Clearance For Test To Diagnose B-Cell Lymphoma
13 Jan 2025 //
PR NEWSWIRE
Roche`s Chugai turns to Swiss biotech Araris for ADC deal
10 Jan 2025 //
FIERCE BIOTECH
Roche to complete $1.5 B acquisition of Poseida
09 Jan 2025 //
PRESS RELEASE
Roche projected to claim pharma`s 2025 sales crown
03 Jan 2025 //
FIERCE PHARMA
Innovent Enters into Agreement with Roche for Novel DLL3 ADC
02 Jan 2025 //
PR NEWSWIRE
Rapt pays $35M for challenger to Novartis, Roche drug
24 Dec 2024 //
FIERCE BIOTECH
Roche’s Prasinezumab Study Misses Primary Endpoint in PD
19 Dec 2024 //
GLOBENEWSWIRE
Roche`s Prothena-partnered Parkinson`s prospect fails phase 2b
19 Dec 2024 //
FIERCE BIOTECH
China-made lung cancer drug plays catch-up with Pfizer, Roche
19 Dec 2024 //
FIERCE PHARMA
Roche’s Prothena-partnered Parkinson’s prospect fails phase 2b
19 Dec 2024 //
FIERCE BIOTECH
Eylea HD passes test in retinal vein occlusion, teeing up filing
18 Dec 2024 //
FIERCE PHARMA
Roche Launches cobas® Mass Spec Solution for Diagnostics
18 Dec 2024 //
GLOBENEWSWIRE
Roche culls ph. 3 Spark gene therapy in hemophilia
18 Dec 2024 //
FIERCE BIOTECH
AbbVie buys Roche spinout Nimble Therapeutics for $200M
14 Dec 2024 //
PRESS RELEASE
Roche Receives CE Mark for Updated Molecular 6800/8800 Systems
12 Dec 2024 //
GLOBENEWSWIRE
Roche’s Vabysmo PFS Approved for Three Retinal Conditions in EU
12 Dec 2024 //
GLOBENEWSWIRE
Roche’s Columvi & Lunsumio Data Reinforce Lymphoma Outcomes at ASH
10 Dec 2024 //
GLOBENEWSWIRE
A look at how Roche`s $1.5B Poseida buyout came together
10 Dec 2024 //
FIERCE BIOTECH
Roche`s subQ Lunsumio matches IV version in lymphoma
10 Dec 2024 //
FIERCE PHARMA
Roche Launches Tender Offer for Poseida Therapeutics Shares
09 Dec 2024 //
GLOBENEWSWIRE
ASH: Lilly defends survival data blemish in novel BTK trial win
09 Dec 2024 //
FIERCE PHARMA
Roche’s Polivy Confirmed as Standard for Lymphoma Treatment
08 Dec 2024 //
GLOBENEWSWIRE
FDA Accepts BLA for Roche’s Columvi Combo for large B-cell lymphoma
05 Dec 2024 //
GLOBENEWSWIRE
Roche Partners With COUR in Autoimmune Deal Worth $900M
04 Dec 2024 //
BIOSPACE
Roche records setback in phase III study of two lung cancer drugs
26 Nov 2024 //
REUTERS
Roche agreement to acquire Poseida Therapeutics
26 Nov 2024 //
GLOBENEWSWIRE
Roche Receives FDA Approval for Diagnostic in Biliary Tract Cancer
25 Nov 2024 //
PR NEWSWIRE
Roche files patent suit to fend off potential Evrysdi generics
20 Nov 2024 //
FIERCE PHARMA
Revelation Pharma Congratulates David on NH State Senate Election
19 Nov 2024 //
PR NEWSWIRE
Neuron23 to Use Roche’s Digital Biomarker in Parkinson’s Trial
19 Nov 2024 //
BUSINESSWIRE
Neuron23 Unveils Phase 2 Trial in Early Parkinson’s Disease
19 Nov 2024 //
BUSINESSWIRE
Roche Receives CE Mark for VENTANA FOLR1 Assay in Ovarian Cancer
18 Nov 2024 //
PR NEWSWIRE
Flare Therapeutics Enters Discovery Collaboration with Roche
14 Nov 2024 //
BUSINESSWIRE
Roche stakes over $1.8B on cancer-linked transcription factors
13 Nov 2024 //
BIOSPACE
Flare Therapeutics Partners with Roche to Target Transcription Factors
12 Nov 2024 //
PR NEWSWIRE
Genentech axes Nykode cancer vaccine deal
09 Nov 2024 //
FIERCE BIOTECH
Vaccinex Reports Immunity Benefit with Pepinemab at SITC Meeting
05 Nov 2024 //
GLOBENEWSWIRE
Roche Presents Long-Term Data Across Hematology Portfolio at ASH
05 Nov 2024 //
GLOBENEWSWIRE
Genentech to Share Long-term Data at ASH 2024 Hematology
05 Nov 2024 //
BUSINESSWIRE
PredicineCARE Featured in NEJM for Roche’s Ph 3 Breast Cancer Trial
04 Nov 2024 //
GLOBENEWSWIRE
UCB`s tau drug flunks Alzheimer`s trial days after Roche`s exit
01 Nov 2024 //
FIERCE BIOTECH
Roche collects more data on blood tests for Alzheimer’s disease
31 Oct 2024 //
FIERCE BIOTECH
Vaccinex Reports SIGNAL-AD Data for Pepinemab at CTAD
31 Oct 2024 //
GLOBENEWSWIRE
Publishes Ph 3 Results for Roche’s Itovebi in HR+ve Breast Cancer
31 Oct 2024 //
GLOBENEWSWIRE
Roche Presents Alzheimer’s Diagnostics Data at CTAD
31 Oct 2024 //
GLOBENEWSWIRE
Patient death prompts Roche to adjust Alzheimer`s trial
31 Oct 2024 //
FIERCE PHARMA
